Fermentation Pharma / API - Listed on 18 August 2023
Concord Biotech (Fermentation Pharma / API) closed its IPO window in 2023 and listed on NSE and BSE on 18 August 2023 at an upper band issue price of Rs 741, opening at Rs 900.05 for a listing gain of +21.5% and closing day one at Rs 942.8 (+27.2% on closing basis). The IPO was subscribed 24.86x overall - QIB 67.67x, HNI/NII 16.99x, Retail 3.78x. The total issue size was Rs 1,550.52 Cr (Fresh Issue Rs 0 Cr, OFS Rs 1550.52 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Fermentation Pharma / API
Concord Biotech operates in the Fermentation Pharma / API space. The company’s listed profile is shaped by its operating niche, customer demand and ability to convert that demand into steady cash flows. Investors should read its exchange filings alongside the headline listing numbers for a fuller view of the business.
Issue structure, listing outcome and context
The Concord Biotech issue was offered at an upper price of Rs 741 and raised approximately Rs 1,550.52 crore. The final outcome reflected a mix of subscription demand, valuation, market conditions and the company’s own operating story. Fresh issue and offer-for-sale details, where available, are shown in the issue metrics below.
Number of times each investor category subscribed by close of Day 3.
How overall subscription built up across the three-day issue window.
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | Rs 220 | +29.69% |
| Day 2 | Rs 170 | +22.94% |
| Day 3 | Rs 170 | +22.94% |
| Day 4 | Rs 180 | +24.29% |
| Day 5 | Rs 160 | +21.59% |
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
How the broader market moved around the Concord Biotech IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Concord Biotech IPO listed at +21.5% versus the upper issue price of Rs 741 on 18 August 2023.
Concord Biotech IPO was subscribed 24.86x overall. QIB portion was subscribed 67.67x, HNI / NII 16.99x and Retail 3.78x.
IPO GMP started at Rs 220 on Day 1 and moved to Rs 160 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.